These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15096050)

  • 1. Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein.
    Bussell R; Eliezer D
    Biochemistry; 2004 Apr; 43(16):4810-8. PubMed ID: 15096050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational properties of alpha-synuclein in its free and lipid-associated states.
    Eliezer D; Kutluay E; Bussell R; Browne G
    J Mol Biol; 2001 Apr; 307(4):1061-73. PubMed ID: 11286556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein.
    Bussell R; Eliezer D
    J Biol Chem; 2001 Dec; 276(49):45996-6003. PubMed ID: 11590151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.
    Bodner CR; Maltsev AS; Dobson CM; Bax A
    Biochemistry; 2010 Feb; 49(5):862-71. PubMed ID: 20041693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins.
    Bussell R; Eliezer D
    J Mol Biol; 2003 Jun; 329(4):763-78. PubMed ID: 12787676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J; Uversky VN; Fink AL
    Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis.
    Jo E; Darabie AA; Han K; Tandon A; Fraser PE; McLaurin J
    Eur J Biochem; 2004 Aug; 271(15):3180-9. PubMed ID: 15265037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins.
    Sharon R; Goldberg MS; Bar-Josef I; Betensky RA; Shen J; Selkoe DJ
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9110-5. PubMed ID: 11481478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
    Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M
    FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.
    Lashuel HA; Petre BM; Wall J; Simon M; Nowak RJ; Walz T; Lansbury PT
    J Mol Biol; 2002 Oct; 322(5):1089-102. PubMed ID: 12367530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
    Coskuner O; Wise-Scira O
    ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.
    Volles MJ; Lee SJ; Rochet JC; Shtilerman MD; Ding TT; Kessler JC; Lansbury PT
    Biochemistry; 2001 Jul; 40(26):7812-9. PubMed ID: 11425308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Parkinson disease mutations influence α-synuclein assembly.
    Ono K; Ikeda T; Takasaki J; Yamada M
    Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lipid-binding domain of wild type and mutant alpha-synuclein: compactness and interconversion between the broken and extended helix forms.
    Georgieva ER; Ramlall TF; Borbat PP; Freed JH; Eliezer D
    J Biol Chem; 2010 Sep; 285(36):28261-74. PubMed ID: 20592036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.
    Narhi L; Wood SJ; Steavenson S; Jiang Y; Wu GM; Anafi D; Kaufman SA; Martin F; Sitney K; Denis P; Louis JC; Wypych J; Biere AL; Citron M
    J Biol Chem; 1999 Apr; 274(14):9843-6. PubMed ID: 10092675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.